Print

Vanderbilt University Medical Center Study Finds Diverse Genetic Alterations in Triple-Negative Breast Cancers  
12/10/2012 7:47:45 AM

Most triple-negative breast cancer patients who were treated with chemotherapy to shrink the tumor prior to surgery still had multiple genetic mutations in their tumor cells, according to a study by Vanderbilt-Ingram Cancer Center (VICC) investigators. Finding multiple mutations instead of just one primary mutation that can be targeted for therapy sheds more light on the challenges of treating triple-negative breast cancer.
//-->